TrialJournal of Crohn's & colitis2026

Histologic and combined histologic-endoscopic outcomes with mirikizumab in Crohn's disease: VIVID-1 trial results.

Vipul Jairath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.